TY - JOUR
T1 - Secreted Phospholipases A2 Are Intestinal Stem Cell Niche Factors with Distinct Roles in Homeostasis, Inflammation, and Cancer
AU - Schewe, Matthias
AU - Franken, Patrick F.
AU - Sacchetti, Andrea
AU - Schmitt, Mark
AU - Joosten, Rosalie
AU - Böttcher, René
AU - van Royen, Martin E.
AU - Jeammet, Louise
AU - Payré, Christine
AU - Scott, Patricia M.
AU - Webb, Nancy R.
AU - Gelb, Michael
AU - Cormier, Robert T.
AU - Lambeau, Gérard
AU - Fodde, Riccardo
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - The intestinal stem cell niche provides cues that actively maintain gut homeostasis. Dysregulation of these cues may compromise intestinal regeneration upon tissue insult and/or promote tumor growth. Here, we identify secreted phospholipases A2 (sPLA2s) as stem cell niche factors with context-dependent functions in the digestive tract. We show that group IIA sPLA2, a known genetic modifier of mouse intestinal tumorigenesis, is expressed by Paneth cells in the small intestine, while group X sPLA2 is expressed by Paneth/goblet-like cells in the colon. During homeostasis, group IIA/X sPLA2s inhibit Wnt signaling through intracellular activation of Yap1. However, upon inflammation they are secreted into the intestinal lumen, where they promote prostaglandin synthesis and Wnt signaling. Genetic ablation of both sPLA2s improves recovery from inflammation but increases colon cancer susceptibility due to release of their homeostatic Wnt-inhibitory role. This “trade-off” effect suggests sPLA2s have important functions as genetic modifiers of inflammation and colon cancer.
AB - The intestinal stem cell niche provides cues that actively maintain gut homeostasis. Dysregulation of these cues may compromise intestinal regeneration upon tissue insult and/or promote tumor growth. Here, we identify secreted phospholipases A2 (sPLA2s) as stem cell niche factors with context-dependent functions in the digestive tract. We show that group IIA sPLA2, a known genetic modifier of mouse intestinal tumorigenesis, is expressed by Paneth cells in the small intestine, while group X sPLA2 is expressed by Paneth/goblet-like cells in the colon. During homeostasis, group IIA/X sPLA2s inhibit Wnt signaling through intracellular activation of Yap1. However, upon inflammation they are secreted into the intestinal lumen, where they promote prostaglandin synthesis and Wnt signaling. Genetic ablation of both sPLA2s improves recovery from inflammation but increases colon cancer susceptibility due to release of their homeostatic Wnt-inhibitory role. This “trade-off” effect suggests sPLA2s have important functions as genetic modifiers of inflammation and colon cancer.
UR - http://www.scopus.com/inward/record.url?scp=85006765674&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85006765674&partnerID=8YFLogxK
U2 - 10.1016/j.stem.2016.05.023
DO - 10.1016/j.stem.2016.05.023
M3 - Article
C2 - 27292189
AN - SCOPUS:85006765674
SN - 1934-5909
VL - 19
SP - 38
EP - 51
JO - Cell Stem Cell
JF - Cell Stem Cell
IS - 1
ER -